Radiation oncologist, Dr. Mark Amsbaugh of UTHealth Houston, explains how newer local therapies are offering advanced prostate cancer patients additional options for managing their disease and improving outcomes.
Content independently created by SurvivorNet with support from Novartis Pharmaceuticals Corp.
Read More
